招惹 发表于 2025-3-25 03:47:08

http://reply.papertrans.cn/23/2220/221970/221970_21.png

inscribe 发表于 2025-3-25 11:08:10

http://reply.papertrans.cn/23/2220/221970/221970_22.png

免费 发表于 2025-3-25 14:40:05

http://reply.papertrans.cn/23/2220/221970/221970_23.png

辫子带来帮助 发表于 2025-3-25 17:12:20

Connections with number theory,he efficacy or effectiveness of lifestyle interventions. This chapter will summarize key challenges in developing evidence-based recommendations for non-pharmacological interventions for ASCVD risk reduction.

Decibel 发表于 2025-3-25 23:42:29

http://reply.papertrans.cn/23/2220/221970/221970_25.png

fluffy 发表于 2025-3-26 00:08:09

http://reply.papertrans.cn/23/2220/221970/221970_26.png

Arroyo 发表于 2025-3-26 05:19:13

Evolution of Cardiovascular Outcomes Studiesas myocardial infarction and stroke. Several study design components, including blinding, comparator groups, population, outcome variables, and follow-up durations, must be considered in the design and interpretation of a CVOT.

北极人 发表于 2025-3-26 10:57:49

Statistical Methods for Cardiovascular Outcomes Studiesoaches; observational studies; randomized and target trials; statistical power; and sample size considerations. While not exhaustive, these fundamental topics are framed with functional examples in cardiology.

职业拳击手 发表于 2025-3-26 15:25:35

http://reply.papertrans.cn/23/2220/221970/221970_29.png

禁令 发表于 2025-3-26 17:23:06

The arithmetic of quadratic forms,ally on current and future therapies for lipid lowering. Our review is meant to assist in recognizing dyslipidemia in a clinical setting, identifying the most frequent causes of potential lipid derangements, and determining appropriate strategies to guide shared decision-making with the goal of reducing cardiovascular disease risk.
页: 1 2 [3] 4 5 6
查看完整版本: Titlebook: Cardiovascular Outcomes Research; A Clinician’s Guide Kevin C. Maki,Don P. Wilson Book 2024 The Editor(s) (if applicable) and The Author(s